A Study to Enroll Patients of Rheumatic Diseases and First-degree Relatives in a Biobank


About this study

The purpose of this study is to enroll rheumatic disease patients and first-degree relatives in a biobank, and to follow them over time to assess health outcomes and collect additional specimens.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients ≥ 18 years of age.
  • Must be able to provide informed consent.
  • Diagnosis of a rheumatic disease by a rheumatologist; i.e.:
    • Rheumatoid arthritis;
    • Psoriatic arthritis;
    • Ankylosing spondylitis;
    • Arthritis associated with inflammatory bowel disease;
    • Undifferentiated spondyloarthritis;
    • Systemic lupus erythematosus;
    • Sjogren’s syndrome;
    • Scleroderma/systemic sclerosis;
    • Polymyositis;
    • Dermatomyositis;
    • Mixed connective tissue disease;
    • Granulomatosis with polyangiitis;
    • Microscopic polyangiitis;
    • ANCA-associated vasculitis;
    • Giant cell arteritis;
    • Takayasu arteritis;
    • Polyarteritis nodosa;
    • Drug-induced rheumatic disorders.
  • First-degree relative of a patient with a diagnosis of a rheumatic disease.

Exclusion Criteria:

  • Individuals who do not comprehend English:
    • Participants must be able to read and sign a consent form without the assistance of an interpreter.
  • Individuals who are unable to sign consent:
    • mentally challenged;
    • declared legally incompetent.
  • Individuals regarded as belonging to a vulnerable population:
    • prisoners.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

John Davis, M.D.

Closed-enrolling by invitation

What is this? (?)
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Jennifer Sletten



More information


Publications are currently not available

Mayo Clinic Footer